August 4, 2023 For 14 years, the Gillings School, Merck and NCI have leveraged an enduring collaboration to improve the efficiency of drug development, allowing safe and effective medications to reach patients sooner and make a significant impact on public health.
April 12, 2023 New research led by the Gillings School shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.
September 27, 2022 A new JAMA study of more than 10 million North Carolinians highlights just how effective COVID-19 vaccines, boosters and prior infection can be, both in reducing the risk of future infection and in preventing hospitalization and death.
September 15, 2022 Dr. Danyu Lin led research recently published in the New England Journal of Medicine that assesses the level of immunity conferred by COVID-19 vaccination or previous SARS-CoV-2 infection among children. The findings provide crucial information for making decisions about vaccine boosters for children.
January 12, 2022 A study published in the New England Journal of Medicine shows that, despite breakthrough infections, COVID-19 vaccines are highly effective at preventing hospitalization and death. The findings support the use of boosters to provide ongoing protection.
April 27, 2021 The large-scale deployment of effective vaccines is globally recognized as the best way to end the COVID-19 pandemic. However, the high efficacy reported for vaccines currently in use — like Pfizer and Moderna — is based on an average follow-up time of only about two months after the second dose. The question remains: Will people need booster vaccinations?
December 4, 2020 Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have developed a computational framework to generate evidence-based optimal cancer treatment decisions informed by a patient’s genomic biomarkers. The findings, which may aid in the development of precision cancer treatments, are published in the Journal of the American Statistical Association.
March 16, 2020 As countries around the globe work to slow the spread of the novel coronavirus SARS-CoV-2 — which causes the illness COVID-19 — researchers and practitioners in every discipline at the Gillings School are turning their expertise into action to support the pandemic response.
March 1, 2019
The Gillings School's Collaborative Studies Coordinating Center has been awarded a seven-year, $23 million grant from the National Institutes of Health to continue the Hispanic Community Health Study/Study of Latinos. The historic study is the largest-ever prospective epidemiological study of this diverse population.
October 2, 2017 Dr. Anastasia Ivanova will lead a five-year, $61 million study to identify more effective treatments for asthma attacks and will do so by combining two important tools -- precision medicine and 'big data' analysis. The work is funded by the National Heart, Lung and Blood Institute.
